Neurobion drives Merck Consumer Health

17 May 2018 - Deborah Wilkes

Archived

Germany's Merck says its Consumer Health business, which is set to be acquired by Procter & Gamble, recorded "very strong organic growth" in the first quarter of 2018. The Neurobion range of nerve-care products led the way with worldwide sales up by around a tenth.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: